FA
EIGR
Forefront Analytics’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-51,679
| Closed | -$46.3K | – | 77 |
|
|
2023
Q1 | $46.3K | Buy |
51,679
+39,300
| +317% | +$35.2K | 0.02% | 74 |
|
|
2022
Q4 | $14.6K | Buy |
+12,379
| New | +$14.6K | 0.01% | 75 |
|
|
2022
Q3 | – | Sell |
-11,527
| Closed | -$73K | – | 70 |
|
|
2022
Q2 | $73K | Buy |
11,527
+700
| +6% | +$4.43K | 0.04% | 55 |
|
|
2022
Q1 | $87K | Buy |
10,827
+475
| +5% | +$3.82K | 0.03% | 64 |
|
|
2021
Q4 | $58K | Buy |
10,352
+275
| +3% | +$1.54K | 0.02% | 62 |
|
|
2021
Q3 | $68K | Buy |
10,077
+50
| +0.5% | +$337 | 0.02% | 64 |
|
|
2021
Q2 | $82K | Sell |
10,027
-736
| -7% | -$6.02K | 0.03% | 63 |
|
|
2021
Q1 | $97K | Buy |
+10,763
| New | +$97K | 0.04% | 64 |
|